 |
|
Antiretroviral Therapy in HIV Infection
Are Neurologically Active Drugs Important?
Lucette A. J. Cysique, MA;
Paul Maruff, PhD;
Bruce J. Brew, MBBS, MD, FRACP
Arch Neurol. 2004;61:1699-1704.
Background The effect on neuropsychological function of antiretroviral drugs that are able to penetrate into the brain in effective concentration (neuroactive drugs) remains unclear.
Objective To investigate whether highly active antiretroviral therapy (HAART) containing neuroactive drugs is associated with better neuropsychological performance in patients with human immunodeficiency virus disease.
Design Cross-sectional survey.
Setting Tertiary referral hospital outpatient clinics.
Patients The study population consisted of 97 individuals positive for human immunodeficiency virus (stage C3, 1993 Centers for Disease Control and Prevention classification) whose condition had been stable on their current HAART regimen for a mean ± SD of 18.5 ± 16.5 months and who were aged 48.14 ± 9.38 years. The patient groups were analyzed according to whether their regimen contained 3 or more neuroactive drugs (neuroHAART group; n = 41) or not (HAART group; n = 56). Thirty seronegative men matched for age and education were recruited as controls.
Main Outcome Measure Neuropsychological performance on 7 cognitive domains.
Results The neuroHAART and HAART groups did not differ from one another on neuropsychological performance, but both patient groups were impaired compared with controls. Impaired patients in each treatment group were compared, and the neuroHAART group showed significantly better memory performance, unrelated to plasma viral load, than the HAART group.
Conclusion No direct benefit of neuroactive HAART therapy was found in patients with advanced human immunodeficiency virus infection. However, in neuropsychologically impaired patients, there was a benefit in memory function. This suggests that a threshold of neuropsychological impairment is required for the benefit of neuroactive HAART.
Author Affiliations: Faculty of Medicine, St Vincent’s Clinical School, University of New South Wales, Sydney, Australia (Ms Cysique); School of Psychology, LaTrobe University, Melbourne, Australia (Dr Maruff); and Departments of Neurology and HIV Medicine, St Vincent’s Hospital, Sydney (Dr Brew).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region
Wright et al.
Neurology 2008;71:50-56.
ABSTRACT
| FULL TEXT
HIV-associated dementia: An inconvenient truth
Brew and Gonzalez-Scarano
Neurology 2007;68:324-325.
FULL TEXT
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients
Cysique et al.
Neurology 2006;66:1447-1450.
ABSTRACT
| FULL TEXT
Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline
Thompson et al.
Proc. Natl. Acad. Sci. USA 2005;102:15647-15652.
ABSTRACT
| FULL TEXT
|
